John Rex

President & Chief Financial Officer, Unitedhealth

Search every verified John Rex interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. John Rex, President and Chief Financial Officer at UnitedHealth Group, spoke during the company’s third quarter 2026 earnings call on October 13, 2026. He discussed the performance of the company’s pharmacy benefit manager (PBM), OptumRx, noting that recent selling seasons have been strong and that this trend is expected to continue. Rex attributed this momentum to the company’s transformation and transparency modernization efforts, stating that every OptumRx client benefits from a fully transparent supply chain instrumentation. He also mentioned that retention rates remain in the high 90s and that the company has aligned its broker and marketing strategies to support stability in its base business and growth in areas of opportunity. Rex also commented on the company’s specialty pharmacy operations, saying that while overall volumes declined by 5% for the quarter, specialty volumes increased by 2.6%. He credited this growth to initiatives focused on winning on provider choice and improving the customer experience. His remarks were part of a broader discussion in which company leadership highlighted progress in 2026 and expressed confidence in the outlook for 2027, while acknowledging ongoing trend pressures in the marketplace.